Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-154677
Filing Date
2022-05-19
Accepted
2022-05-19 10:32:31
Documents
2
Group Members
ALLEGRO INVESTMENT FUND, L.P.ALLEGRO INVESTMENT INC.ALLEGRO INVESTORS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d349200dsc13da.htm SC 13D/A 102498
2 EX-99.A d349200dex99a.htm EX-99.A 5131
  Complete submission text file 0001193125-22-154677.txt   109094
Mailing Address 3000 SAND HILL ROAD BUILDING 3, SUITE 105 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 3, SUITE 105 MENLO PARK CA 94025 (415) 889-0550
Sight Sciences, Inc. (Subject) CIK: 0001531177 (see all company filings)

EIN.: 800625749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92715 | Film No.: 22941550
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address
Encrantz Staffan (Filed by) CIK: 0001870875 (see all company filings)

Type: SC 13D/A